0
Sleep Disorders |

The Unexpected Results of a Prospective Study: Effect of CPAP on Blood Pressure Values in Patients With Obstructive Sleep Apnea Syndrome Associating Severe Resistant Hypertension

Oana Deleanu; Andra Malaut; Alexandra Sandu; Ruxandra Ulmeanu; Florin Mihaltan
Author and Funding Information

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania


Chest. 2014;146(4_MeetingAbstracts):951A. doi:10.1378/chest.1992845
Text Size: A A A
Published online

Abstract

SESSION TITLE: Sleep Posters II

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PM

PURPOSE: There are few studies regarding the effect of CPAP on blood pressure (BP) values in patients with OSAS and resistant hypertension (RHT), reporting a small and not homogenous BP reduction in patients with BP values very close to normal; only one study analyzed BP after 6 months of CPAP treatment. We analyzed the modification in BP measured with 48h ABPM in CPAP treated patients, comparing values from baseline with those at 3 and 6 months.

METHODS: We studied 27 patients without secondary RHT, mild OSAS, central SAS, hypercapnia, insomnia, restless legs syndrome, CPAP failure (manual PSG titration), modifying HT medication during the study, poor CPAP compliance (<4 h in >70% days used).

RESULTS: 11 patients using CPAP completed the 6 months evaluation: 8 men (73%), mean age 55.1±7.0 years, mean IAH 66.9±20.0/h, baseline SBP 166.6±20.1mmHg and DBP 93.9±12.5mmHg, diagnosed with HT for 11.2±10.9 years, CPAP compliance 5.9±1.2h/night. Only significant difference in BP values was an increase of nocturnal maximum SBP from 3 to 6 months (178.0±22.4 to 204.4±29.0 mmHg, p=0.02), without any significant differences regarding the ABPM dipper pattern, mean/diurnal/nocturnal SBP and DBP or measured by sphygmomanometer, from baseline to 3 or 6 months. The patients were well controlled regarding OSAS by CPAP treatment, with a mean residual AHI=2.84/h, with a significant reduction in Epworth score under CPAP from baseline 10.3±5.7 to 4.0±3.8 after 3 months (p=0.004) and to 1.3±1.2 (p=0.001) after 6 months, with a significant improvement in quality of life (SAQLI) from baseline 4.5±1.5 to 6.3±0.7 after 3 months (p=0.002) and to 6.5±0.4 (p=0.001) after 6 months. This is an on going study and the purpose of this analyze was to compare the modification in BP values within the same group of patients with severe uncontrolled RHT.

CONCLUSIONS: These unexpected results regarding BP values can be justified by myocardial and vascular remodeling after long period of uncontrolled severe RHT. The period of accommodation with CPAP and the psychological burden of disease, with a good compliance but increasing in time can also influence the response of BP values.

CLINICAL IMPLICATIONS: The results achieved after 6 months of CPAP treatment, without rapid improvements in this severe uncontrolled RHT group must not be disappointing, because long term follow-up is needed to establish without any doubt the effect of CPAP in lowering BP and in terms of other compounds, eg. cardiovascular risk assessment.

DISCLOSURE: The following authors have nothing to disclose: Oana Deleanu, Andra Malaut, Alexandra Sandu, Ruxandra Ulmeanu, Florin Mihaltan

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543